ChitogenX Inc.

CHNXFOTCHealthcare● Active

$0.01

+$0.00(+0.00%)

Market Cap$627628

P/E Ratio—

52W High$0.0165

52W Low$0.0011

Avg Volume26K

Open$0.00

Beta-2.10

Overview

ChitogenX Inc. (CHNXF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CHNXF · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2024Report Date: Dec 22, 2024

EPS Actual

-$0.01

Est. -$0.01 · -39.5%

Revenue

—

Fiscal Period

Q4 FY2024

FY ends December

Report Date

Dec 22, 2024

After Market Close

▼ Miss EPS

CHNXF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	Jun 30, 2026	-$0.02	—	—	—	—	—
◌ Q2 FY2026	Jun 8, 2026	-$0.01	—	—	—	—	—
◌ Q2 FY2026	Apr 1, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 23, 2026	-$0.02	—	—	—	—	—
◌ Q3 FY2025	Jul 18, 2025	—	—	—	—	—	—
▼ Q4 FY2024	Dec 22, 2024	-$0.01	-$0.01	-39.5%	—	—	—
▲ Q3 FY2024	Sep 27, 2024	-$0.01	-$0.00	+60.1%	—	—	—
▲ Q1 FY2024	Jan 31, 2024	-$0.01	-$0.00	+72.5%	—	—	—

Q2 FY2026

Jun 30, 2026

EPS Actual

—

EPS Est.

-$0.02

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 8, 2026

EPS Actual

—

EPS Est.

-$0.01

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 1, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 23, 2026

EPS Actual

—

EPS Est.

-$0.02

EPS Surpr.

—

Revenue

—

Q3 FY2025

Jul 18, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 22, 2024Miss

EPS Actual

-$0.01

EPS Est.

-$0.01

EPS Surpr.

-39.5%

Revenue

—

Q3 FY2024

Sep 27, 2024Beat

EPS Actual

-$0.00

EPS Est.

-$0.01

EPS Surpr.

+60.1%

Revenue

—

Q1 FY2024

Jan 31, 2024Beat

EPS Actual

-$0.00

EPS Est.

-$0.01

EPS Surpr.

+72.5%

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q2 FY2030	$-0.01	$-0.01	$-0.01	1
Q1 FY2030	$-0.01	$-0.01	$-0.01	1
Q4 FY2029	$-0.01	$-0.01	$-0.01	1
Q3 FY2029	$-0.02	$-0.02	$-0.02	1
Q2 FY2029	$-0.02	$-0.02	$-0.02	1
Q1 FY2029	$-0.02	$-0.02	$-0.02	1

Revenue Estimates

Period	Low	Consensus	High
Q2 FY2030	$0.0B	$0.0B	$0.0B
Q1 FY2030	$0.0B	$0.0B	$0.0B
Q4 FY2029	$0.0B	$0.0B	$0.0B
Q3 FY2029	$0.0B	$0.0B	$0.0B
Q2 FY2029	$0.0B	$0.0B	$0.0B
Q1 FY2029	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q4 FY2024	Dec 22, 2024	-39.5%	$0.02	$0.02	+0.00%
▲ Q3 FY2024	Sep 27, 2024	+60.1%	$0.02	$0.02	+0.00%
▲ Q1 FY2024	Jan 31, 2024	+72.5%	$0.07	$0.06	-3.08%
▲ Q1 FY2024	Jan 2, 2024	+0.0%	$0.05	$0.05	+0.43%
▲ Q3 FY2023	Sep 29, 2023	+50.0%	$0.09	$0.09	+0.00%
▲ Q2 FY2023	Jun 29, 2023	+0.0%	$0.09	$0.09	+0.00%
— Q1 FY2023	Jan 31, 2023	—	$0.17	$0.17	+0.00%

Q4 FY2024+0.00%

Report Date

Dec 22, 2024

EPS Beat/Miss

-39.5%

Price Before

$0.02

Price After

$0.02

Q3 FY2024+0.00%

Report Date

Sep 27, 2024

EPS Beat/Miss

+60.1%

Price Before

$0.02

Price After

$0.02

Q1 FY2024-3.08%

Report Date

Jan 31, 2024

EPS Beat/Miss

+72.5%

Price Before

$0.07

Price After

$0.06

Q1 FY2024+0.43%

Report Date

Jan 2, 2024

EPS Beat/Miss

+0.0%

Price Before

$0.05

Price After

$0.05

Q3 FY2023+0.00%

Report Date

Sep 29, 2023

EPS Beat/Miss

+50.0%

Price Before

$0.09

Price After

$0.09

Q2 FY2023+0.00%

Report Date

Jun 29, 2023

EPS Beat/Miss

+0.0%

Price Before

$0.09

Price After

$0.09

Q1 FY2023+0.00%

Report Date

Jan 31, 2023

EPS Beat/Miss

—

Price Before

$0.17

Price After

$0.17

Avg Beat Reaction-0.53%

Avg Miss Reaction+0.00%

Beat Rate5 / 7 quarters

Largest Move-3.08% (Q1 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

ChitogenX Inc. (CHNXF) most recently reported earnings on December 22, 2024 for Q4 FY2024, posting EPS of $-0.01 — missing the analyst consensus of $-0.01 by -39.5%. The next CHNXF earnings date is expected around September 1, 2026.

Each quarter, investors track CHNXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CHNXF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

CHNXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

CHNXF earnings · 5 questions

ChitogenX Inc.'s next earnings report is expected around September 1, 2026. CHNXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CHNXF historically reports after market close (AMC).

CHNXF earnings datewhen is CHNXF earningsCHNXF next earnings datewhen does CHNXF report earningsCHNXF earnings calendar

▸ Source: FMP · ChitogenX Inc. SEC filings · US GAAP · ChitogenX Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026